| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/15/1999 | WO1999035492A1 Method and apparatus for determining blood oxygen transport |
| 07/15/1999 | WO1999035491A2 Method for detecting growth and stress in plants and for monitoring textile fiber quality |
| 07/15/1999 | WO1999035487A1 Methods and apparatus for accurate analysis of bodily fluid constituents |
| 07/15/1999 | WO1999035486A1 Immunoassay fluorometer |
| 07/15/1999 | WO1999035483A1 Device, method and apparatus for implementing the method, for dosing at least a particular constituent in a product sample |
| 07/15/1999 | WO1999035481A1 A method for detecting venting of a combustion appliance within an improper space |
| 07/15/1999 | WO1999035292A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | WO1999035289A1 Polymeric arrays and methods for their use in binding assays |
| 07/15/1999 | WO1999035288A1 Enzyme-specific cleavable polynucleotide substrate and assay method |
| 07/15/1999 | WO1999035283A1 Methods and reagents for modulating cell motility |
| 07/15/1999 | WO1999035275A1 Human genetic sequences which are homologous to the yeast genes involved in the proteolytic processing of prenylated proteins |
| 07/15/1999 | WO1999035272A1 RECOMBINANT P37/FlaA AS A DIAGNOSTIC REAGENT |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035265A1 Human vps35/mem3-related protein |
| 07/15/1999 | WO1999035259A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | WO1999035255A2 Compositions and methods for regulated secretion from neuroendocrine cell lines |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035245A2 Methods for preparing and using immortalized human neuroendocrine cells |
| 07/15/1999 | WO1999035242A1 Media for neuroendocrine cells |
| 07/15/1999 | WO1999035169A2 Methods and compositions for treating and diagnosing insulin related disorders |
| 07/15/1999 | WO1999035167A1 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients |
| 07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035106A2 Mammalian edg-7 receptor homologs |
| 07/15/1999 | WO1999034984A1 Labeling technique for countering product diversion and product counterfeiting |
| 07/15/1999 | WO1999034920A1 Method and apparatus for performing microassays |
| 07/15/1999 | WO1999034817A1 Agent for treating allergic or hypersensitivity condition |
| 07/15/1999 | WO1999034806A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA) |
| 07/15/1999 | WO1999034781A1 Brain aging assay |
| 07/15/1999 | WO1999034670A1 Gene mutant animals |
| 07/15/1999 | WO1999027366A3 Method of detecting prostate specific antigen activation peptide |
| 07/15/1999 | WO1999026070A3 Method for automatic implementation of chemical or biological methods |
| 07/15/1999 | WO1999024602A3 Process for determining cell vitality and efficiency in parallel |
| 07/15/1999 | WO1999024466A3 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
| 07/15/1999 | WO1999023489B1 Reagent and method for differential determination of leukocytes in blood |
| 07/15/1999 | WO1999022241B1 Elisa for interstitial cystitis and bladder cancer |
| 07/15/1999 | WO1999021582A3 Application of tnf antagonists as medicaments for treating septic diseases |
| 07/15/1999 | WO1999019363B1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | WO1998053066A9 Smad2 phosphorylation and interaction with smad4 |
| 07/15/1999 | DE19813759C1 Inducing a natural killer cell immune response ex vivo |
| 07/15/1999 | DE19801243A1 New avian vitelline anti-conglutinin antibodies useful for diagnosing mastitis |
| 07/15/1999 | DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum |
| 07/15/1999 | DE19800899A1 Preparation of oligo-ligands for macromolecules with optionally unknown composition of building blocks |
| 07/15/1999 | DE19800887A1 Column measuring parameters associated with liquid transport in porous media |
| 07/15/1999 | DE19758399A1 Spectral analysis of edible oil mixture components especially for detecting Soya oil in olive oil |
| 07/15/1999 | DE19743938C1 Coating amino-activated surfaces with polyalkylene oxide |
| 07/15/1999 | CA2351624A1 Compounds and methods for modulating tissue permeability |
| 07/15/1999 | CA2325049A1 Mammalian edg-7 receptor homologs |
| 07/15/1999 | CA2324972A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2318380A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | CA2318379A1 Identification of substances that modify cellular secretory function |
| 07/15/1999 | CA2318376A1 Compositions and methods for regulated secretion from neuroendocrine cell lines |
| 07/15/1999 | CA2317898A1 Human vps35/mem3-related protein |
| 07/15/1999 | CA2317809A1 Gene mutant animals |
| 07/15/1999 | CA2317674A1 Methods and compositions for treating and diagnosing insulin related disorders |
| 07/15/1999 | CA2317653A1 Method for identifying validated target and assay combinations |
| 07/15/1999 | CA2317463A1 Screening method for apoptosis and necrosis |
| 07/15/1999 | CA2316833A1 Device, method and apparatus for implementing the method, for dosing at least a particular constituent in a product sample |
| 07/15/1999 | CA2316824A1 Improved magnetic particles, method for obtaining same and uses for separating molecules |
| 07/15/1999 | CA2316269A1 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients |
| 07/15/1999 | CA2312848A1 Polymeric arrays and methods for their use in binding assays |
| 07/15/1999 | CA2312173A1 Method comprising capture molecule fixed on disc surface |
| 07/15/1999 | CA2283494A1 Recombinant p37/flaa as a diagnostic reagent |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928969A2 Hollow frustum reagent test device |
| 07/14/1999 | EP0928968A1 Screening method for apoptosis and necrosis |
| 07/14/1999 | EP0928967A2 Method and apparatus for the determination of a substance coexisting with another substance |
| 07/14/1999 | EP0928963A2 Crown shear testing apparatus with dynamic load |
| 07/14/1999 | EP0928962A1 Exhaust gas measuring instrument |
| 07/14/1999 | EP0928421A1 Standard solution for the determination of thyroid function |
| 07/14/1999 | EP0928420A1 Homogeneous binding assay |
| 07/14/1999 | EP0928417A1 Apparatus and method for measuring the content of intramuscular fat in carcasses or parts thereof |
| 07/14/1999 | EP0928416A1 Lens and associatable flow cell |
| 07/14/1999 | EP0928342A1 The use of modular oligonucleotides as probes or primers in nucleic acid based assay |
| 07/14/1999 | EP0928340A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 07/14/1999 | EP0928327A1 Solid phase enrichment of intact cells using intracellular constituents |
| 07/14/1999 | EP0928311A1 Shaping object with reactive functions |
| 07/14/1999 | EP0928301A1 Fluid composition for physiological separations |
| 07/14/1999 | EP0928295A1 Purification of immunoglobulins |
| 07/14/1999 | EP0928293A1 Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity |
| 07/14/1999 | EP0928201A1 Novel glycolipid complexes and their uses |
| 07/14/1999 | EP0928155A1 Monitoring system for the regular intake of a medicament |
| 07/14/1999 | EP0871877A4 Method and apparatus for the measurement of dissolved carbon |
| 07/14/1999 | EP0784699B1 Assay and reagent kit for the quantitative in vitro determination in biological specimens of the activity of proteins causing multi-drug resistance in tumors |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0741870B1 Method for quantifying lbp in body fluids |
| 07/14/1999 | EP0635126B1 Detection of microorganisms and determination of their sensitivity to antibiotics |
| 07/14/1999 | EP0574414B1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 07/14/1999 | EP0287653B1 Hormone receptor compositions and methods |
| 07/14/1999 | CN2329000Y Table for drawing and detecting cloth machine |
| 07/14/1999 | CN1222968A Apparatus and method for characterizing fiber crimps |
| 07/14/1999 | CN1222940A Biochemical analysis of antioxidant function |
| 07/14/1999 | CN1222936A Recombinant protein containing c-terminal fragment of plasmodium MSP-1 |
| 07/14/1999 | CN1222935A Compounds and method for immunotherapy and immunodiagnosis of prostate cancer |
| 07/14/1999 | CN1222917A Novel protein and process for producing the same |
| 07/14/1999 | CN1222678A Triptolide content determining method |
| 07/14/1999 | CN1222677A Diluent and blood solvent cleaning liquid for blood cell counter and their preparation |
| 07/14/1999 | CN1222607A Highly concentrated aqueous suspension of minerals and/or fillers and/or pigments |